Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Synthetic Oligonucleotides Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Column-Based Oligos
1.2.3 Array-Based Oligos
1.3 Market by Application
1.3.1 Global Synthetic Oligonucleotides Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Genetic Testing
1.3.3 Pharmacy
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Synthetic Oligonucleotides Market Perspective (2018-2033)
2.2 Synthetic Oligonucleotides Growth Trends by Region
2.2.1 Global Synthetic Oligonucleotides Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Synthetic Oligonucleotides Historic Market Size by Region (2018-2023)
2.2.3 Synthetic Oligonucleotides Forecasted Market Size by Region (2024-2033)
2.3 Synthetic Oligonucleotides Market Dynamics
2.3.1 Synthetic Oligonucleotides Industry Trends
2.3.2 Synthetic Oligonucleotides Market Drivers
2.3.3 Synthetic Oligonucleotides Market Challenges
2.3.4 Synthetic Oligonucleotides Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Synthetic Oligonucleotides Players by Revenue
3.1.1 Global Top Synthetic Oligonucleotides Players by Revenue (2018-2023)
3.1.2 Global Synthetic Oligonucleotides Revenue Market Share by Players (2018-2023)
3.2 Global Synthetic Oligonucleotides Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Synthetic Oligonucleotides Revenue
3.4 Global Synthetic Oligonucleotides Market Concentration Ratio
3.4.1 Global Synthetic Oligonucleotides Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Synthetic Oligonucleotides Revenue in 2022
3.5 Synthetic Oligonucleotides Key Players Head office and Area Served
3.6 Key Players Synthetic Oligonucleotides Product Solution and Service
3.7 Date of Enter into Synthetic Oligonucleotides Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Synthetic Oligonucleotides Breakdown Data by Type
4.1 Global Synthetic Oligonucleotides Historic Market Size by Type (2018-2023)
4.2 Global Synthetic Oligonucleotides Forecasted Market Size by Type (2024-2033)
5 Synthetic Oligonucleotides Breakdown Data by Application
5.1 Global Synthetic Oligonucleotides Historic Market Size by Application (2018-2023)
5.2 Global Synthetic Oligonucleotides Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Synthetic Oligonucleotides Market Size (2018-2033)
6.2 North America Synthetic Oligonucleotides Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Synthetic Oligonucleotides Market Size by Country (2018-2023)
6.4 North America Synthetic Oligonucleotides Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Synthetic Oligonucleotides Market Size (2018-2033)
7.2 Europe Synthetic Oligonucleotides Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Synthetic Oligonucleotides Market Size by Country (2018-2023)
7.4 Europe Synthetic Oligonucleotides Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Synthetic Oligonucleotides Market Size (2018-2033)
8.2 Asia-Pacific Synthetic Oligonucleotides Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Synthetic Oligonucleotides Market Size by Region (2018-2023)
8.4 Asia-Pacific Synthetic Oligonucleotides Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Synthetic Oligonucleotides Market Size (2018-2033)
9.2 Latin America Synthetic Oligonucleotides Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Synthetic Oligonucleotides Market Size by Country (2018-2023)
9.4 Latin America Synthetic Oligonucleotides Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Synthetic Oligonucleotides Market Size (2018-2033)
10.2 Middle East & Africa Synthetic Oligonucleotides Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Synthetic Oligonucleotides Market Size by Country (2018-2023)
10.4 Middle East & Africa Synthetic Oligonucleotides Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck KGaA
11.1.1 Merck KGaA Company Detail
11.1.2 Merck KGaA Business Overview
11.1.3 Merck KGaA Synthetic Oligonucleotides Introduction
11.1.4 Merck KGaA Revenue in Synthetic Oligonucleotides Business (2018-2023)
11.1.5 Merck KGaA Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Detail
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Synthetic Oligonucleotides Introduction
11.2.4 Thermo Fisher Scientific Revenue in Synthetic Oligonucleotides Business (2018-2023)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Creative Biolabs
11.3.1 Creative Biolabs Company Detail
11.3.2 Creative Biolabs Business Overview
11.3.3 Creative Biolabs Synthetic Oligonucleotides Introduction
11.3.4 Creative Biolabs Revenue in Synthetic Oligonucleotides Business (2018-2023)
11.3.5 Creative Biolabs Recent Development
11.4 Danaher Corporation
11.4.1 Danaher Corporation Company Detail
11.4.2 Danaher Corporation Business Overview
11.4.3 Danaher Corporation Synthetic Oligonucleotides Introduction
11.4.4 Danaher Corporation Revenue in Synthetic Oligonucleotides Business (2018-2023)
11.4.5 Danaher Corporation Recent Development
11.5 Eurofins Scientific SE
11.5.1 Eurofins Scientific SE Company Detail
11.5.2 Eurofins Scientific SE Business Overview
11.5.3 Eurofins Scientific SE Synthetic Oligonucleotides Introduction
11.5.4 Eurofins Scientific SE Revenue in Synthetic Oligonucleotides Business (2018-2023)
11.5.5 Eurofins Scientific SE Recent Development
11.6 Agilent Technologies, Inc.
11.6.1 Agilent Technologies, Inc. Company Detail
11.6.2 Agilent Technologies, Inc. Business Overview
11.6.3 Agilent Technologies, Inc. Synthetic Oligonucleotides Introduction
11.6.4 Agilent Technologies, Inc. Revenue in Synthetic Oligonucleotides Business (2018-2023)
11.6.5 Agilent Technologies, Inc. Recent Development
11.7 GE Healthcare
11.7.1 GE Healthcare Company Detail
11.7.2 GE Healthcare Business Overview
11.7.3 GE Healthcare Synthetic Oligonucleotides Introduction
11.7.4 GE Healthcare Revenue in Synthetic Oligonucleotides Business (2018-2023)
11.7.5 GE Healthcare Recent Development
11.8 Kaneka Eurogentec S.A.
11.8.1 Kaneka Eurogentec S.A. Company Detail
11.8.2 Kaneka Eurogentec S.A. Business Overview
11.8.3 Kaneka Eurogentec S.A. Synthetic Oligonucleotides Introduction
11.8.4 Kaneka Eurogentec S.A. Revenue in Synthetic Oligonucleotides Business (2018-2023)
11.8.5 Kaneka Eurogentec S.A. Recent Development
11.9 GeneDesign, Inc.
11.9.1 GeneDesign, Inc. Company Detail
11.9.2 GeneDesign, Inc. Business Overview
11.9.3 GeneDesign, Inc. Synthetic Oligonucleotides Introduction
11.9.4 GeneDesign, Inc. Revenue in Synthetic Oligonucleotides Business (2018-2023)
11.9.5 GeneDesign, Inc. Recent Development
11.10 LGC Biosearch Technologies
11.10.1 LGC Biosearch Technologies Company Detail
11.10.2 LGC Biosearch Technologies Business Overview
11.10.3 LGC Biosearch Technologies Synthetic Oligonucleotides Introduction
11.10.4 LGC Biosearch Technologies Revenue in Synthetic Oligonucleotides Business (2018-2023)
11.10.5 LGC Biosearch Technologies Recent Development
11.11 Bio-synthesis Inc.
11.11.1 Bio-synthesis Inc. Company Detail
11.11.2 Bio-synthesis Inc. Business Overview
11.11.3 Bio-synthesis Inc. Synthetic Oligonucleotides Introduction
11.11.4 Bio-synthesis Inc. Revenue in Synthetic Oligonucleotides Business (2018-2023)
11.11.5 Bio-synthesis Inc. Recent Development
11.12 GeneWorks Pty Ltd
11.12.1 GeneWorks Pty Ltd Company Detail
11.12.2 GeneWorks Pty Ltd Business Overview
11.12.3 GeneWorks Pty Ltd Synthetic Oligonucleotides Introduction
11.12.4 GeneWorks Pty Ltd Revenue in Synthetic Oligonucleotides Business (2018-2023)
11.12.5 GeneWorks Pty Ltd Recent Development
11.13 Integrated DNA Technologies, Inc
11.13.1 Integrated DNA Technologies, Inc Company Detail
11.13.2 Integrated DNA Technologies, Inc Business Overview
11.13.3 Integrated DNA Technologies, Inc Synthetic Oligonucleotides Introduction
11.13.4 Integrated DNA Technologies, Inc Revenue in Synthetic Oligonucleotides Business (2018-2023)
11.13.5 Integrated DNA Technologies, Inc Recent Development
11.14 BioAutomation
11.14.1 BioAutomation Company Detail
11.14.2 BioAutomation Business Overview
11.14.3 BioAutomation Synthetic Oligonucleotides Introduction
11.14.4 BioAutomation Revenue in Synthetic Oligonucleotides Business (2018-2023)
11.14.5 BioAutomation Recent Development
11.15 Twist Bioscience
11.15.1 Twist Bioscience Company Detail
11.15.2 Twist Bioscience Business Overview
11.15.3 Twist Bioscience Synthetic Oligonucleotides Introduction
11.15.4 Twist Bioscience Revenue in Synthetic Oligonucleotides Business (2018-2023)
11.15.5 Twist Bioscience Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Synthetic Oligonucleotides Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Column-Based Oligos
Table 3. Key Players of Array-Based Oligos
Table 4. Global Synthetic Oligonucleotides Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Synthetic Oligonucleotides Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Synthetic Oligonucleotides Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Synthetic Oligonucleotides Market Share by Region (2018-2023)
Table 8. Global Synthetic Oligonucleotides Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Synthetic Oligonucleotides Market Share by Region (2024-2033)
Table 10. Synthetic Oligonucleotides Market Trends
Table 11. Synthetic Oligonucleotides Market Drivers
Table 12. Synthetic Oligonucleotides Market Challenges
Table 13. Synthetic Oligonucleotides Market Restraints
Table 14. Global Synthetic Oligonucleotides Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Synthetic Oligonucleotides Market Share by Players (2018-2023)
Table 16. Global Top Synthetic Oligonucleotides Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Synthetic Oligonucleotides as of 2022)
Table 17. Ranking of Global Top Synthetic Oligonucleotides Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Synthetic Oligonucleotides Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Synthetic Oligonucleotides Product Solution and Service
Table 21. Date of Enter into Synthetic Oligonucleotides Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Synthetic Oligonucleotides Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Synthetic Oligonucleotides Revenue Market Share by Type (2018-2023)
Table 25. Global Synthetic Oligonucleotides Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Synthetic Oligonucleotides Revenue Market Share by Type (2024-2033)
Table 27. Global Synthetic Oligonucleotides Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Synthetic Oligonucleotides Revenue Market Share by Application (2018-2023)
Table 29. Global Synthetic Oligonucleotides Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Synthetic Oligonucleotides Revenue Market Share by Application (2024-2033)
Table 31. North America Synthetic Oligonucleotides Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Synthetic Oligonucleotides Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Synthetic Oligonucleotides Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Synthetic Oligonucleotides Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Synthetic Oligonucleotides Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Synthetic Oligonucleotides Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Synthetic Oligonucleotides Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Synthetic Oligonucleotides Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Synthetic Oligonucleotides Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Synthetic Oligonucleotides Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Synthetic Oligonucleotides Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Synthetic Oligonucleotides Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Synthetic Oligonucleotides Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Synthetic Oligonucleotides Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Synthetic Oligonucleotides Market Size by Country (2024-2033) & (US$ Million)
Table 46. Merck KGaA Company Detail
Table 47. Merck KGaA Business Overview
Table 48. Merck KGaA Synthetic Oligonucleotides Product
Table 49. Merck KGaA Revenue in Synthetic Oligonucleotides Business (2018-2023) & (US$ Million)
Table 50. Merck KGaA Recent Development
Table 51. Thermo Fisher Scientific Company Detail
Table 52. Thermo Fisher Scientific Business Overview
Table 53. Thermo Fisher Scientific Synthetic Oligonucleotides Product
Table 54. Thermo Fisher Scientific Revenue in Synthetic Oligonucleotides Business (2018-2023) & (US$ Million)
Table 55. Thermo Fisher Scientific Recent Development
Table 56. Creative Biolabs Company Detail
Table 57. Creative Biolabs Business Overview
Table 58. Creative Biolabs Synthetic Oligonucleotides Product
Table 59. Creative Biolabs Revenue in Synthetic Oligonucleotides Business (2018-2023) & (US$ Million)
Table 60. Creative Biolabs Recent Development
Table 61. Danaher Corporation Company Detail
Table 62. Danaher Corporation Business Overview
Table 63. Danaher Corporation Synthetic Oligonucleotides Product
Table 64. Danaher Corporation Revenue in Synthetic Oligonucleotides Business (2018-2023) & (US$ Million)
Table 65. Danaher Corporation Recent Development
Table 66. Eurofins Scientific SE Company Detail
Table 67. Eurofins Scientific SE Business Overview
Table 68. Eurofins Scientific SE Synthetic Oligonucleotides Product
Table 69. Eurofins Scientific SE Revenue in Synthetic Oligonucleotides Business (2018-2023) & (US$ Million)
Table 70. Eurofins Scientific SE Recent Development
Table 71. Agilent Technologies, Inc. Company Detail
Table 72. Agilent Technologies, Inc. Business Overview
Table 73. Agilent Technologies, Inc. Synthetic Oligonucleotides Product
Table 74. Agilent Technologies, Inc. Revenue in Synthetic Oligonucleotides Business (2018-2023) & (US$ Million)
Table 75. Agilent Technologies, Inc. Recent Development
Table 76. GE Healthcare Company Detail
Table 77. GE Healthcare Business Overview
Table 78. GE Healthcare Synthetic Oligonucleotides Product
Table 79. GE Healthcare Revenue in Synthetic Oligonucleotides Business (2018-2023) & (US$ Million)
Table 80. GE Healthcare Recent Development
Table 81. Kaneka Eurogentec S.A. Company Detail
Table 82. Kaneka Eurogentec S.A. Business Overview
Table 83. Kaneka Eurogentec S.A. Synthetic Oligonucleotides Product
Table 84. Kaneka Eurogentec S.A. Revenue in Synthetic Oligonucleotides Business (2018-2023) & (US$ Million)
Table 85. Kaneka Eurogentec S.A. Recent Development
Table 86. GeneDesign, Inc. Company Detail
Table 87. GeneDesign, Inc. Business Overview
Table 88. GeneDesign, Inc. Synthetic Oligonucleotides Product
Table 89. GeneDesign, Inc. Revenue in Synthetic Oligonucleotides Business (2018-2023) & (US$ Million)
Table 90. GeneDesign, Inc. Recent Development
Table 91. LGC Biosearch Technologies Company Detail
Table 92. LGC Biosearch Technologies Business Overview
Table 93. LGC Biosearch Technologies Synthetic Oligonucleotides Product
Table 94. LGC Biosearch Technologies Revenue in Synthetic Oligonucleotides Business (2018-2023) & (US$ Million)
Table 95. LGC Biosearch Technologies Recent Development
Table 96. Bio-synthesis Inc. Company Detail
Table 97. Bio-synthesis Inc. Business Overview
Table 98. Bio-synthesis Inc. Synthetic Oligonucleotides Product
Table 99. Bio-synthesis Inc. Revenue in Synthetic Oligonucleotides Business (2018-2023) & (US$ Million)
Table 100. Bio-synthesis Inc. Recent Development
Table 101. GeneWorks Pty Ltd Company Detail
Table 102. GeneWorks Pty Ltd Business Overview
Table 103. GeneWorks Pty Ltd Synthetic Oligonucleotides Product
Table 104. GeneWorks Pty Ltd Revenue in Synthetic Oligonucleotides Business (2018-2023) & (US$ Million)
Table 105. GeneWorks Pty Ltd Recent Development
Table 106. Integrated DNA Technologies, Inc Company Detail
Table 107. Integrated DNA Technologies, Inc Business Overview
Table 108. Integrated DNA Technologies, Inc Synthetic Oligonucleotides Product
Table 109. Integrated DNA Technologies, Inc Revenue in Synthetic Oligonucleotides Business (2018-2023) & (US$ Million)
Table 110. Integrated DNA Technologies, Inc Recent Development
Table 111. BioAutomation Company Detail
Table 112. BioAutomation Business Overview
Table 113. BioAutomation Synthetic Oligonucleotides Product
Table 114. BioAutomation Revenue in Synthetic Oligonucleotides Business (2018-2023) & (US$ Million)
Table 115. BioAutomation Recent Development
Table 116. Twist Bioscience Company Detail
Table 117. Twist Bioscience Business Overview
Table 118. Twist Bioscience Synthetic Oligonucleotides Product
Table 119. Twist Bioscience Revenue in Synthetic Oligonucleotides Business (2018-2023) & (US$ Million)
Table 120. Twist Bioscience Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Synthetic Oligonucleotides Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Synthetic Oligonucleotides Market Share by Type: 2022 VS 2033
Figure 3. Column-Based Oligos Features
Figure 4. Array-Based Oligos Features
Figure 5. Global Synthetic Oligonucleotides Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Synthetic Oligonucleotides Market Share by Application: 2022 VS 2033
Figure 7. Genetic Testing Case Studies
Figure 8. Pharmacy Case Studies
Figure 9. Other Case Studies
Figure 10. Synthetic Oligonucleotides Report Years Considered
Figure 11. Global Synthetic Oligonucleotides Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Synthetic Oligonucleotides Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Synthetic Oligonucleotides Market Share by Region: 2022 VS 2033
Figure 14. Global Synthetic Oligonucleotides Market Share by Players in 2022
Figure 15. Global Top Synthetic Oligonucleotides Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Synthetic Oligonucleotides as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Synthetic Oligonucleotides Revenue in 2022
Figure 17. North America Synthetic Oligonucleotides Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Synthetic Oligonucleotides Market Share by Country (2018-2033)
Figure 19. United States Synthetic Oligonucleotides Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Canada Synthetic Oligonucleotides Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe Synthetic Oligonucleotides Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Synthetic Oligonucleotides Market Share by Country (2018-2033)
Figure 23. Germany Synthetic Oligonucleotides Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. France Synthetic Oligonucleotides Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. U.K. Synthetic Oligonucleotides Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Italy Synthetic Oligonucleotides Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Russia Synthetic Oligonucleotides Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Nordic Countries Synthetic Oligonucleotides Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific Synthetic Oligonucleotides Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Synthetic Oligonucleotides Market Share by Region (2018-2033)
Figure 31. China Synthetic Oligonucleotides Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Japan Synthetic Oligonucleotides Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. South Korea Synthetic Oligonucleotides Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Southeast Asia Synthetic Oligonucleotides Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. India Synthetic Oligonucleotides Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Australia Synthetic Oligonucleotides Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America Synthetic Oligonucleotides Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Synthetic Oligonucleotides Market Share by Country (2018-2033)
Figure 39. Mexico Synthetic Oligonucleotides Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Brazil Synthetic Oligonucleotides Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa Synthetic Oligonucleotides Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Synthetic Oligonucleotides Market Share by Country (2018-2033)
Figure 43. Turkey Synthetic Oligonucleotides Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Saudi Arabia Synthetic Oligonucleotides Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Merck KGaA Revenue Growth Rate in Synthetic Oligonucleotides Business (2018-2023)
Figure 46. Thermo Fisher Scientific Revenue Growth Rate in Synthetic Oligonucleotides Business (2018-2023)
Figure 47. Creative Biolabs Revenue Growth Rate in Synthetic Oligonucleotides Business (2018-2023)
Figure 48. Danaher Corporation Revenue Growth Rate in Synthetic Oligonucleotides Business (2018-2023)
Figure 49. Eurofins Scientific SE Revenue Growth Rate in Synthetic Oligonucleotides Business (2018-2023)
Figure 50. Agilent Technologies, Inc. Revenue Growth Rate in Synthetic Oligonucleotides Business (2018-2023)
Figure 51. GE Healthcare Revenue Growth Rate in Synthetic Oligonucleotides Business (2018-2023)
Figure 52. Kaneka Eurogentec S.A. Revenue Growth Rate in Synthetic Oligonucleotides Business (2018-2023)
Figure 53. GeneDesign, Inc. Revenue Growth Rate in Synthetic Oligonucleotides Business (2018-2023)
Figure 54. LGC Biosearch Technologies Revenue Growth Rate in Synthetic Oligonucleotides Business (2018-2023)
Figure 55. Bio-synthesis Inc. Revenue Growth Rate in Synthetic Oligonucleotides Business (2018-2023)
Figure 56. GeneWorks Pty Ltd Revenue Growth Rate in Synthetic Oligonucleotides Business (2018-2023)
Figure 57. Integrated DNA Technologies, Inc Revenue Growth Rate in Synthetic Oligonucleotides Business (2018-2023)
Figure 58. BioAutomation Revenue Growth Rate in Synthetic Oligonucleotides Business (2018-2023)
Figure 59. Twist Bioscience Revenue Growth Rate in Synthetic Oligonucleotides Business (2018-2023)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed